VitalConnect CEO Nersi Nazari talks data with Host Steve Krupa in this episode of the Breaking Health podcast. VitalConnect has developed a line of sensors capable of tracking conditions of patients at home and in the hospital. According to the company, its VitalPatch wearable biosensor is a lightweight, wireless, and records eight patient vital signs. The VitalConnect Platform integrates the VitalPatch biosensor with mobile and cloud-based software and analytics. The company closed on $33 million in a Series C last year, drawing capital from Baxter Ventures and MVM Life Sciences.